Mainz Biomed (MYNZ) Change in Account Payables (2021 - 2025)
Historic Change in Account Payables for Mainz Biomed (MYNZ) over the last 5 years, with Q2 2025 value amounting to $1.1 million.
- Mainz Biomed's Change in Account Payables fell 6058.47% to $1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year decrease of 6058.47%. This contributed to the annual value of $2295.1 billion for FY2024, which is 7207224310.22% up from last year.
- As of Q2 2025, Mainz Biomed's Change in Account Payables stood at $1.1 million, which was down 6058.47% from $2295.1 billion recorded in Q4 2024.
- Over the past 5 years, Mainz Biomed's Change in Account Payables peaked at $2295.1 billion during Q4 2024, and registered a low of -$342326.0 during Q3 2022.
- In the last 5 years, Mainz Biomed's Change in Account Payables had a median value of $1.5 million in 2022 and averaged $191.3 billion.
- Per our database at Business Quant, Mainz Biomed's Change in Account Payables tumbled by 7421.04% in 2023 and then skyrocketed by 47352895372.92% in 2024.
- Over the past 5 years, Mainz Biomed's Change in Account Payables (Quarter) stood at $784786.0 in 2021, then surged by 139.47% to $1.9 million in 2022, then plummeted by 74.21% to $484671.0 in 2023, then soared by 473528953.73% to $2295.1 billion in 2024, then crashed by 100.0% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q2 2025, $2295.1 billion for Q4 2024, and $2.9 million during Q2 2024.